Time-Restricted Feeding and Breast Cancer
Time-Restricted Feeding and Breast Cancer
批准号:
9882965
负责人:
NICHOLAS J WEBSTER
金额:
$35.46万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2022-03-31
关键词:
AddressAgeAllelesAlzheimer&aposs DiseaseAnimalsAnti-Inflammatory AgentsAntigensBackcrossingsBiological MarkersBody Weight decreasedBreast Cancer CellBreast Cancer ModelBreast Cancer Risk FactorBreast Epithelial CellsCaloric RestrictionCarcinogensCell TransplantationChemicalsChronicClinical DataColon CarcinomaConsumptionDataDiagnosisDietDietary InterventionDyslipidemiasEatingEnergy IntakeEpidemiologyEstrogensFastingFatty AcidsFatty acid glycerol estersFemaleGrowthHigh Fat DietHistopathologyHormone replacement therapyHormonesHourHumanHungerHyperinsulinismHypertensionIncidenceIndividualInflammationInflammatoryInjectionsInsulinInsulin ResistanceIntermittent fastingInterventionLeadLinkLongitudinal StudiesMalignant NeoplasmsMalignant neoplasm of liverMammary NeoplasmsMammary glandMenopauseMeta-AnalysisMetabolicMetabolic syndromeModelingMolecularMouse Mammary Tumor VirusMusNeoplasm MetastasisObese MiceObesityOmega-3 Fatty AcidsOmega-6 Fatty AcidsOncogenesOvarianOvariectomyOvaryPharmacologyPhasePhysiologicalPolycystic Ovary SyndromePolyomavirusPostmenopausePremenopauseProtocols documentationRag1 MouseResistanceRiskRodentSaturated Fatty AcidsSignal TransductionSteroidsStrokeTNF geneTailTestingTimeTime-restricted feedingTissuesTransgenic OrganismsTumor Necrosis Factor ReceptorTumor TissueVeinsWomanbasecancer biomarkerscancer initiationcancer riskcytokinediabetes riskdietary manipulationfeeding schedulegenetic manipulationimprovedin vivoinsulin sensitivityinsulin sensitizing drugsmalemalignant breast neoplasmmouse modelneoplastic cellnovelovotoxicitypublic health relevanceresponsetime usetransplant modeltumortumor growthtumor initiation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): There is abundant evidence that obesity confers increased risk for various forms of cancer. The incidence of breast, colon, and liver cancer are all increased in obese populations, and the epidemiologic evidence for the obesity-breast cancer connection is particularly strong. One in eight women will be diagnosed with breast cancer during their lifetime. Breast cancer is incidence increases 10-fold for women age 60 and above, compared to women 50 or younger. The increased breast cancer risk seems to be related to post- menopausal hormone levels, as the increased risk is only seen in women not on hormone replacement therapy. Furthermore the Metabolic Syndrome, which is characterized by obesity, insulin resistance, hypertension, dyslipidemia and elevated risk of diabetes, polycystic ovary syndrome, stroke and Alzheimer's disease, is associated with a higher incidence of more aggressive triple negative breast tumors. The increased risk is accelerated by the decline in ovarian estrogen levels after menopause, as pre-menopausal women are protected from the deleterious metabolic effects of obesity, including chronic tissue inflammation and insulin- resistance. Studies in rodents have confirmed this relationship, showing that dietary-induced obesity and high fat diets lead to increased incidence and growth of tumors in oncogene and carcinogen-induced breast cancers. Despite this body of correlative evidence, the mechanisms of obesity-induced breast cancer risk remain poorly understood. Dietary composition is an important factor as diets rich in saturated and omega 6 fatty acids are pro-inflammatory and increase breast cancer risk, but diets rich in omega 3 fatty acids are anti-inflammatory and decrease cancer risk. The clinical data in humans is less clear but meta-analyses of multiple human breast cancer risk studies have suggested that the ratio of pro-inflammatory to anti-inflammatory fatty acids is the critical factor. Although what you eat is important, when you eat i also important. We have found that reducing inflammation and insulin resistance reduces breast cancer growth in mice. We have also found that a time-restricted, high-fat diet improves insulin resistance despite continuing obesity. Due to the link between obesity, insulin resistance and breast cancer risk in post-menopausal women, and the potential that a similar time-restricted, dietary intervention could protect against breast cancer in humans, we will test the dietary intervention on breast cancer growth in mice and investigate the physiological changes that may drive tumor growth in obesity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ShEEP Request for MESO SECTOR S 600MM Ultra-Sensitive Plate Imager
-
批准号:10741205
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2023
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
SRSF3 degradation in liver disease and hepatocellular carcinoma
-
批准号:10162302
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
SRSF3 degradation in liver disease and hepatocellular carcinoma
-
批准号:10618856
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:10454119
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
SRSF3 degradation in liver disease and hepatocellular carcinoma
-
批准号:10002586
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:10219156
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
SRSF3 degradation in liver disease and hepatocellular carcinoma
-
批准号:10454816
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
BLR&D Research Career Scientist Award Application
-
批准号:10618230
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
SRSF3 Loss and Hepatocellular Carcinoma
-
批准号:9205453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
Time-restricted feeding and breast cancer
-
批准号:10462993
-
项目类别:
-
资助金额:$33.96万
-
财政年份:2016
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
Time-restricted feeding and breast cancer
-
批准号:10709504
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2016
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
Alternative Splicing of the Insulin Receptor Gene
-
批准号:7919020
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
Alternative Splicing of the Insulin Receptor Gene
-
批准号:8259049
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
Alternative Splicing of the Insulin Receptor Gene
-
批准号:8195914
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
Alternative Splicing of the Insulin Receptor Gene
-
批准号:8394584
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
GnRH signaling in LbetaT2 gonadotrope cells
-
批准号:7862228
-
项目类别:
-
资助金额:$0.69万
-
财政年份:2009
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
MECHANISM OF ALTERNATIVE SPLICING OF HUMAN INSULIN RECEPTOR
-
批准号:7723682
-
项目类别:
-
资助金额:$0.81万
-
财政年份:2008
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
GnRH signaling in LbetaT2 gonadotrope cells
-
批准号:7087783
-
项目类别:
-
资助金额:$27.42万
-
财政年份:2005
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
GnRH signaling in LbetaT2 gonadotrope cells
-
批准号:7420898
-
项目类别:
-
资助金额:$26.09万
-
财政年份:2005
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
GnRH signaling in LbetaT2 gonadotrope cells
-
批准号:6984942
-
项目类别:
-
资助金额:$28.08万
-
财政年份:2005
-
负责人:NICHOLAS J WEBSTER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: